252 related articles for article (PubMed ID: 24450648)
1. Pleiotropic molecular effects of the Mycobacterium ulcerans virulence factor mycolactone underlying the cell death and immunosuppression seen in Buruli ulcer.
Hall B; Simmonds R
Biochem Soc Trans; 2014 Feb; 42(1):177-83. PubMed ID: 24450648
[TBL] [Abstract][Full Text] [Related]
2. Buruli ulcer.
Einarsdottir T; Huygen K
Hum Vaccin; 2011 Nov; 7(11):1198-203. PubMed ID: 22048117
[TBL] [Abstract][Full Text] [Related]
3. Mycolactone diffuses from Mycobacterium ulcerans-infected tissues and targets mononuclear cells in peripheral blood and lymphoid organs.
Hong H; Coutanceau E; Leclerc M; Caleechurn L; Leadlay PF; Demangel C
PLoS Negl Trop Dis; 2008; 2(10):e325. PubMed ID: 18941518
[TBL] [Abstract][Full Text] [Related]
4. Skin-specific antibodies neutralizing mycolactone toxin during the spontaneous healing of
Foulon M; Pouchin A; Manry J; Khater F; Robbe-Saule M; Durand A; Esnault L; Delneste Y; Jeannin P; Saint-André JP; Croué A; Altare F; Abel L; Alcaïs A; Marion E
Sci Adv; 2020 Feb; 6(9):eaax7781. PubMed ID: 32133396
[TBL] [Abstract][Full Text] [Related]
5. Buruli ulcer: Advances in understanding Mycobacterium ulcerans infection.
Walsh DS; Portaels F; Meyers WM
Dermatol Clin; 2011 Jan; 29(1):1-8. PubMed ID: 21095521
[TBL] [Abstract][Full Text] [Related]
6. Pathogenetic mechanisms of the intracellular parasite Mycobacterium ulcerans leading to Buruli ulcer.
Silva MT; Portaels F; Pedrosa J
Lancet Infect Dis; 2009 Nov; 9(11):699-710. PubMed ID: 19850228
[TBL] [Abstract][Full Text] [Related]
7. Mycolactone gene expression is controlled by strong SigA-like promoters with utility in studies of Mycobacterium ulcerans and buruli ulcer.
Tobias NJ; Seemann T; Pidot SJ; Porter JL; Marsollier L; Marion E; Letournel F; Zakir T; Azuolas J; Wallace JR; Hong H; Davies JK; Howden BP; Johnson PD; Jenkin GA; Stinear TP
PLoS Negl Trop Dis; 2009 Nov; 3(11):e553. PubMed ID: 19936295
[TBL] [Abstract][Full Text] [Related]
8. Local Cellular Immune Responses and Pathogenesis of Buruli Ulcer Lesions in the Experimental Mycobacterium Ulcerans Pig Infection Model.
Bolz M; Ruggli N; Borel N; Pluschke G; Ruf MT
PLoS Negl Trop Dis; 2016 Apr; 10(4):e0004678. PubMed ID: 27128097
[TBL] [Abstract][Full Text] [Related]
9. Mycolactone toxin induces an inflammatory response by targeting the IL-1β pathway: Mechanistic insight into Buruli ulcer pathophysiology.
Foulon M; Robbe-Saule M; Manry J; Esnault L; Boucaud Y; Alcaïs A; Malloci M; Fanton d'Andon M; Beauvais T; Labarriere N; Jeannin P; Abel L; Saint-André JP; Croué A; Delneste Y; Boneca IG; Marsollier L; Marion E
PLoS Pathog; 2020 Dec; 16(12):e1009107. PubMed ID: 33338061
[TBL] [Abstract][Full Text] [Related]
10. Mycobacterium ulcerans toxic macrolide, mycolactone modulates the host immune response and cellular location of M. ulcerans in vitro and in vivo.
Adusumilli S; Mve-Obiang A; Sparer T; Meyers W; Hayman J; Small PL
Cell Microbiol; 2005 Sep; 7(9):1295-304. PubMed ID: 16098217
[TBL] [Abstract][Full Text] [Related]
11. Mycolactone suppresses T cell responsiveness by altering both early signaling and posttranslational events.
Boulkroun S; Guenin-Macé L; Thoulouze MI; Monot M; Merckx A; Langsley G; Bismuth G; Di Bartolo V; Demangel C
J Immunol; 2010 Feb; 184(3):1436-44. PubMed ID: 20042571
[TBL] [Abstract][Full Text] [Related]
12. Overview: Mycolactone , the Macrolide Toxin of Mycobacterium ulcerans.
Röltgen K; Pluschke G
Methods Mol Biol; 2022; 2387():105-108. PubMed ID: 34643906
[TBL] [Abstract][Full Text] [Related]
13. The One That Got Away: How Macrophage-Derived IL-1β Escapes the Mycolactone-Dependent Sec61 Blockade in Buruli Ulcer.
Hall BS; Hsieh LT; Sacre S; Simmonds RE
Front Immunol; 2021; 12():788146. PubMed ID: 35154073
[TBL] [Abstract][Full Text] [Related]
14. Recent advances: role of mycolactone in the pathogenesis and monitoring of Mycobacterium ulcerans infection/Buruli ulcer disease.
Sarfo FS; Phillips R; Wansbrough-Jones M; Simmonds RE
Cell Microbiol; 2016 Jan; 18(1):17-29. PubMed ID: 26572803
[TBL] [Abstract][Full Text] [Related]
15. Antibody-Mediated Neutralization of the Exotoxin Mycolactone, the Main Virulence Factor Produced by Mycobacterium ulcerans.
Dangy JP; Scherr N; Gersbach P; Hug MN; Bieri R; Bomio C; Li J; Huber S; Altmann KH; Pluschke G
PLoS Negl Trop Dis; 2016 Jun; 10(6):e0004808. PubMed ID: 27351976
[TBL] [Abstract][Full Text] [Related]
16. Buruli ulcer: reductive evolution enhances pathogenicity of Mycobacterium ulcerans.
Demangel C; Stinear TP; Cole ST
Nat Rev Microbiol; 2009 Jan; 7(1):50-60. PubMed ID: 19079352
[TBL] [Abstract][Full Text] [Related]
17. FVB/N Mice Spontaneously Heal Ulcerative Lesions Induced by Mycobacterium ulcerans and Switch M. ulcerans into a Low Mycolactone Producer.
Marion E; Jarry U; Cano C; Savary C; Beauvillain C; Robbe-Saule M; Preisser L; Altare F; Delneste Y; Jeannin P; Marsollier L
J Immunol; 2016 Mar; 196(6):2690-8. PubMed ID: 26873988
[TBL] [Abstract][Full Text] [Related]
18. Development of an ELISA for the quantification of mycolactone, the cytotoxic macrolide toxin of Mycobacterium ulcerans.
Warryn L; Dangy JP; Gersbach P; Gehringer M; Schäfer A; Ruf MT; Ruggli N; Altmann KH; Pluschke G
PLoS Negl Trop Dis; 2020 Jun; 14(6):e0008357. PubMed ID: 32589646
[TBL] [Abstract][Full Text] [Related]
19. Immunity against Mycobacterium ulcerans: The subversive role of mycolactone.
Demangel C
Immunol Rev; 2021 May; 301(1):209-221. PubMed ID: 33607704
[TBL] [Abstract][Full Text] [Related]
20. Cellular immunity confers transient protection in experimental Buruli ulcer following BCG or mycolactone-negative Mycobacterium ulcerans vaccination.
Fraga AG; Martins TG; Torrado E; Huygen K; Portaels F; Silva MT; Castro AG; Pedrosa J
PLoS One; 2012; 7(3):e33406. PubMed ID: 22413022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
